Advertisement

Hyperhidrosis in Children

  • Samantha Neves
  • John Robert Pires-Davidson
  • Dafne Braga Diamante Leiderman
  • Nelson Wolosker
Chapter

Abstract

Hyperhidrosis in children, as in adults, is characterized by excessive sweating, but diagnosis before the age of 18 years is delicate and must meet certain criteria. The major problems that this disease can cause are the implications and emotional repercussions of social rejection. Over the years these problems can be aggravated and the child can become an adult with behavioral, self-esteem, and relationship problems. The treatment of hyperhidrosis may involve multiple approaches that are isolated, combined, or even superimposed in cases of non-adherence, intolerance, or failure. The main treatments are topical treatment (antiperspirants), iontophoresis, botulinum toxin, laser, microwave, surgical treatment, and systemic treatment with oxybutynin.

Keywords

Hyperhidrosis Child Oxybutynin 

Suggested Reading

  1. Bakheit AM, Severa S, Cosgrove A, et al. Safety profile and efficacy of botulinum toxin A (Dysport) in children with muscle spasticity. Dev Med Child Neurol. 2001;43(4):234–8.CrossRefPubMedGoogle Scholar
  2. Bellet JS. Diagnosis and treatment of primary focal hyperhidrosis in children and adolescents. Semin Cutan Med Surg. 2010;29(2):121–6.CrossRefPubMedGoogle Scholar
  3. Buraschi J. Videothoracoscopic sympathicolysis procedure for primary palmar hyperhidrosis in children and adolescents. Arch Argent Pediatr. 2008;106(1):32–5.PubMedGoogle Scholar
  4. Coutinho dos Santos LH, Gomes AM, Giraldi S, et al. Palmar hyperhidrosis: long-term follow-up of nine children and adolescents treated with botulinum toxin type A. Pediatr Dermatol. 2009;26(4):439–44.CrossRefPubMedGoogle Scholar
  5. Dogruk Kacar S, Ozuguz P, Eroglu S, et al. Treatment of primary hyperhidrosis with tap water iontophoresis in paediatric patients: a retrospective analysis. Cutan Ocul Toxicol. 2014;33(4):313–6.CrossRefPubMedGoogle Scholar
  6. Neves S, Uchoa PC, Wolosker N, et al. Long-term comparison of video-assisted thoracic sympathectomy and clinical observation for the treatment of palmar hyperhidrosis in children younger than 14. Pediatr Dermatol. 2012;29(5):575–9.CrossRefPubMedGoogle Scholar
  7. Paller AS, Shah PR, Silverio AM, et al. Oral glycopyrrolate as second-line treatment for primary pediatric hyperhidrosis. J Am Acad Dermatol. 2012;67(5):918–23.CrossRefPubMedGoogle Scholar
  8. Steiner Z, Cohen Z, Kleiner O, et al. Do children tolerate thoracoscopic sympathectomy better than adults? Pediatr Surg Int. 2008;24(3):343–7.CrossRefPubMedGoogle Scholar
  9. Wolosker N, Schvartsman C, Krutman M, et al. Efficacy and quality of life outcomes of oxybutynin for treating palmar hyperhidrosis in children younger than 14 years old. Pediatr Dermatol. 2014;31(1):48–53.CrossRefPubMedGoogle Scholar
  10. Wolosker N, Teivelis MP, Krutman M, et al. Long-term efficacy of oxybutynin for palmar and plantar hyperhidrosis in children younger than 14 years. Pediatr Dermatol. 2014;32(5):663–7.CrossRefPubMedGoogle Scholar

Copyright information

© Springer International Publishing AG, part of Springer Nature 2018

Authors and Affiliations

  • Samantha Neves
    • 1
    • 2
  • John Robert Pires-Davidson
    • 3
  • Dafne Braga Diamante Leiderman
    • 4
  • Nelson Wolosker
    • 5
  1. 1.Brazilian Society of DermatologySão PauloBrazil
  2. 2.School of MedicineABCSanto AndréBrazil
  3. 3.Hospital Universitário Maria Aparecida Pedrossian–UFMSCampo GrandeBrazil
  4. 4.Department of Vascular and Endovascular SurgeryHospital Israelita Albert EinsteinSão PauloBrazil
  5. 5.Department of Vascular and Endovascular SurgeryHospital Israelita Albert EinsteinSão PauloBrazil

Personalised recommendations